Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01463748

Effects of Graptopetalum Paraguayense E. Walther on the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome

Sponsor: Chung Shan Medical University

Interventions Graptopetalum paraguayense E. Walther Placebo

Updated 6 times since 2017 Last updated: Jul 2, 2013 Started: Jul 31, 2011 Primary completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Metabolic Syndrome and is currently completed. Chung Shan Medical University leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Jun 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jul 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chung Shan Medical University
National Science and Technology Council, Taiwan

Data source: Chung Shan Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan